BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/25/2025 7:53:50 AM | Browse: 3 | Download: 0
 |
Received |
|
2024-12-04 08:57 |
 |
Peer-Review Started |
|
2024-12-09 01:57 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2025-01-15 10:15 |
 |
Revised |
|
2025-01-26 13:20 |
 |
Second Decision |
|
2025-02-14 02:59 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2025-02-24 08:01 |
 |
Articles in Press |
|
2025-02-24 08:01 |
 |
Publication Fee Transferred |
|
2025-02-03 00:38 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2025-03-30 07:38 |
 |
Publish the Manuscript Online |
|
2025-04-25 07:53 |
ISSN |
1948-9358 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Pharmacology & Pharmacy |
Manuscript Type |
Basic Study |
Article Title |
Aucubin mitigates the elevation of microglial aerobic glycolysis and inflammation in diabetic neuropathic pain via aldose reductase
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Xue-Zhen Zheng, Hong-Yan Yu, Ye-Ru Chen and Jian-Sheng Fang |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
National Natural Science Foundation of China |
82001424 |
|
Corresponding Author |
Xue-Zhen Zheng, MD, Department of Anesthesiology, The First People's Hospital of Chun'an County, No. 1869 Huanhu North Road, Qiandaohu Town, Chun'an County, Hangzhou 311700, Zhejiang Province, China. zhengxuezhen2024@163.com |
Key Words |
Diabetic neuropathic pain; Aucubin; Glycolysis; Aldose reductase; Microglia |
Core Tip |
Our research demonstrates that Aucubin markedly reduces pain and anxiety-like behavior in Streptozotocin-induced diabetic mice. Furthermore, Aucubin reinstates microglial aerobic glycolysis and mitigates inflammation. Utilizing the SwissTargetPrediction database, we discovered 22 prospective protein targets for Aucubin concerning diabetic neuropathic pain (DNP). Analysis of protein-protein interaction networks and molecular docking experiments identified the potential role of aldose reductase (AKR1B1) to streptozotocin therapy. Aucubin does not repair aerobic glycolysis and inflammation in the setting of AKR1B1 depletion. The findings indicate that Aucubin could be a potential therapeutic drug for DNP, with AKR1B1 identified as a major target. |
Publish Date |
2025-04-25 07:53 |
Citation |
<p>Zheng XZ, Yu HY, Chen YR, Fang JS. Aucubin mitigates the elevation of microglial aerobic glycolysis and inflammation in diabetic neuropathic pain via aldose reductase. <i>World J Diabetes</i> 2025; 16(5): 103915</p> |
URL |
https://www.wjgnet.com/1948-9358/full/v16/i5/103915.htm |
DOI |
https://dx.doi.org/10.4239/wjd.v16.i5.103915 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345